Cargando…
Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis
Objective: The purpose of this article was to assess the benefit of perioperative administration of the intravenous beta-blocker landiolol hydrochloride in preventing atrial fibrillation (AF) after cardiothoracic surgery. Methods: We performed a systematic search in PubMed, Web of Science, CNKI, and...
Autores principales: | Hao, Jianqi, Zhou, Jian, Xu, Wenying, Chen, Cong, Zhang, Jian, Peng, Haoning, Liu, Lunxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915935/ https://www.ncbi.nlm.nih.gov/pubmed/34421096 http://dx.doi.org/10.5761/atcs.ra.21-00126 |
Ejemplares similares
-
Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
por: Aoki, Yoshitaka, et al.
Publicado: (2020) -
Landiolol for managing atrial fibrillation in post-cardiac surgery
por: Fellahi, Jean-Luc, et al.
Publicado: (2018) -
A case of ultrashort‐acting beta‐blocker landiolol hydrochloride for takotsubo syndrome with left ventricular outflow tract obstruction
por: Takama, Takuro, et al.
Publicado: (2018) -
Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study
por: Sakamoto, Atsuhiro, et al.
Publicado: (2019) -
Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)